APA (7th ed.) Citation

J, G., M, L. B., V, M., A, G., S, M., N, P., . . . I, Z. (2023). New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals (Basel, Switzerland), 17(1), . https://doi.org/10.3390/ph17010030

Chicago Style (17th ed.) Citation

J, Guillon, et al. "New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex." Pharmaceuticals (Basel, Switzerland) 17, no. 1 (2023). https://doi.org/10.3390/ph17010030.

MLA (9th ed.) Citation

J, Guillon, et al. "New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex." Pharmaceuticals (Basel, Switzerland), vol. 17, no. 1, 2023, https://doi.org/10.3390/ph17010030.